Skip to content

Quibim

HealthTech·Spain·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns Quibim?

Quibim is a Spanish HealthTech company, currently owned by GoHub Ventures since 2025 and 6 other investors.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
GoHub Ventures
Most recent investor
GoHub Ventures
GoHub Ventures Fund II · 2023 · VC
7 ownership periods · full history below

Key facts

HQSpain
SectorHealthTech
Key takeaways
  • ·Co-held by Clave Mayor, Amadeus Capital Partners, Adara Ventures, K Fund, GoHub Ventures, Asabys Partners and Columbus Venture Partners since 2016.
  • ·7 distinct PE sponsors across ownership cycles.

Ownership history

7 ownership periods · co-invest detected

Co-invest · 7 holders · 2016 · present
Clave Mayor
2016 · present(10yr) · Tech Transfer UPV FCR · 2016 · VC
Adara Ventures
2020 · present(6yr) · Adara Ventures III · 2019 · VC
Amadeus Capital Partners
2020 · present(6yr) · Amadeus IV Digital Prosperity Fund · 2013 · Growth
K Fund
K FundActive
2023 · present(3yr) · Leadwind · 2021 · Growth
Columbus Venture Partners
2025 · present(1yr) · Columbus Life Sciences Fund IV · 2023 · Life Sciences VC
Asabys Partners
2025 · present(1yr) · Sabadell Asabys Health Innovation Investments II · 2023 · Life Sciences VC
GoHub Ventures
2025 · present(1yr) · GoHub Ventures Fund II · 2023 · VC

Questions

Who owns Quibim?

Quibim is currently owned by GoHub Ventures, Asabys Partners and 5 others, through GoHub Ventures Fund II, since 2025.

When did GoHub Ventures and 6 others acquire Quibim?

GoHub Ventures and 6 others acquired Quibim in 2025.

Who has owned Quibim over time?

Quibim has been through 7 private-equity ownership periods: Clave Mayor · via Tech Transfer UPV FCR · since 2016; Amadeus Capital Partners · via Amadeus IV Digital Prosperity Fund · since 2020; Adara Ventures · via Adara Ventures III · since 2020; K Fund · via Leadwind · since 2023; GoHub Ventures · via GoHub Ventures Fund II · since 2025; Asabys Partners · via Sabadell Asabys Health Innovation Investments II · since 2025; Columbus Venture Partners · via Columbus Life Sciences Fund IV · since 2025.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue